Search
F6-734
go.drugbank.com/drugs/DB17444ExperimentalF6-734 is a bispecific monoclonal antibody with affinity for anticarcinoembryonic antigen (CEA) and anti-diethylenetriamine pentaacetic acid (DTPA) (hMN-14 × m734).[A255217,A255222]
Anacaulase
go.drugbank.com/drugs/DB17449ApprovedInvestigationalAnacaulase (anacaulase-bcdb) is a mixture of proteolytic enzymes extracted from the stems of pineapple plants (_Ananas comosus_ [L.] Merr.). … Removing eschar (a process also known as debridement) through surgical procedures can lead to significant trauma, major blood and heat loss and adjacent tissue damage.
MK-4830
go.drugbank.com/drugs/DB17454InvestigationalMK-4830 is a monoclonal antibody that targets the myeloid-specific immunoglobulin-like transcript (ILT) 4 receptor.
Inetetamab
go.drugbank.com/drugs/DB17457InvestigationalInetetamab is a trastuzumab analog. It differs from trastuzumab by a two amino acid variation in its Fc domain (allotype variation), and possesses an exact F(ab’)2 of trastuzumab.
TASO-001
go.drugbank.com/drugs/DB17463InvestigationalTASO-001 is a transforming growth factor (TGF)-beta 2 specific antisense oligodeoxynucleotide.
KF-0210
go.drugbank.com/drugs/DB17476InvestigationalKF-0210 is a small molecule developed by Keythera Pharmaceuticals. It is being investigated for cancers.
BI-836880
go.drugbank.com/drugs/DB17484InvestigationalBI-836880 is a humanized bispecific nanobody that targets VEGF and Ang2.
CPGJ602
go.drugbank.com/drugs/DB17485InvestigationalCPGJ602 is a recombinant anti-EGFR human-mouse chimeric monoclonal antibody.
NY-ESO-1 peptide vaccine
go.drugbank.com/drugs/DB17498InvestigationalIt contains a peptide derived from the cancer-testis antigen (NY-ESO-1).
DSP107
go.drugbank.com/drugs/DB17501InvestigationalDSP107 is a bi-functional, trimeric, fusion protein composed of sequences from the extracellular domain of SIRPα and 4-1BBL.